IL78872A0 - Morphinan derivatives and pharmaceutical compositions containing them - Google Patents
Morphinan derivatives and pharmaceutical compositions containing themInfo
- Publication number
- IL78872A0 IL78872A0 IL78872A IL7887286A IL78872A0 IL 78872 A0 IL78872 A0 IL 78872A0 IL 78872 A IL78872 A IL 78872A IL 7887286 A IL7887286 A IL 7887286A IL 78872 A0 IL78872 A0 IL 78872A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- morphinan derivatives
- morphinan
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3518525 | 1985-05-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL78872A0 true IL78872A0 (en) | 1986-09-30 |
Family
ID=6271435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL78872A IL78872A0 (en) | 1985-05-23 | 1986-05-21 | Morphinan derivatives and pharmaceutical compositions containing them |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS61271275A (fr) |
AU (1) | AU594954B2 (fr) |
BE (1) | BE904796A (fr) |
DK (1) | DK240386A (fr) |
ES (1) | ES8802318A1 (fr) |
FI (1) | FI862124A (fr) |
FR (1) | FR2582309B1 (fr) |
GB (1) | GB2175898B (fr) |
GR (1) | GR861318B (fr) |
HU (1) | HU196376B (fr) |
IL (1) | IL78872A0 (fr) |
IT (1) | IT1203791B (fr) |
LU (1) | LU86435A1 (fr) |
NL (1) | NL8601188A (fr) |
NZ (1) | NZ216250A (fr) |
PH (1) | PH23341A (fr) |
SE (1) | SE8602308L (fr) |
ZA (1) | ZA863873B (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
US4863928A (en) * | 1989-01-04 | 1989-09-05 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for arthritic and inflammatory diseases |
US4923875A (en) * | 1989-07-10 | 1990-05-08 | Baker Cummins Pharmaceuticals, Inc. | Method for treatment of mast cell-mediated dermatologic disorders |
JP2906654B2 (ja) * | 1989-11-28 | 1999-06-21 | 東レ株式会社 | 免疫抑制剤及びその製造方法 |
US5057322A (en) * | 1990-08-10 | 1991-10-15 | Baker Cummins Dermatologicals, Inc. | Method of treating mast cell disease |
NZ246687A (en) * | 1992-01-23 | 1996-12-20 | Toray Industries | Morphinan derivative and pharmaceutical compositions thereof |
EP0661283B1 (fr) * | 1993-07-19 | 1998-10-21 | Toray Industries, Inc. | Agent de protection de cellules cerebrales |
CA2143864C (fr) * | 1993-07-23 | 2006-01-24 | Hiroshi Nagase | Derives de la morphine et leurs utilisations pharmaceutiques |
AR005423A1 (es) * | 1996-01-10 | 1999-06-23 | Smithkline Beecham Spa | Derivados morfinoides condensados con heterociclos (ii), su uso como sustancia terapeutica y para preparar medicamentos, composiciones farmaceuticasque los contienen y procedimiento para preparar dichos derivados. |
ATE291429T1 (de) * | 1996-11-25 | 2005-04-15 | Toray Industries | Mittel gegen juckreiz |
AU6117298A (en) * | 1997-07-25 | 1999-02-16 | Toray Industries, Inc. | Hyponatremia remedies |
US7501433B2 (en) | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US7923454B2 (en) | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
EP2987788A1 (fr) | 2002-05-17 | 2016-02-24 | Taiwanj Pharmaceuticals Co., Ltd. | Composés opioïdes et de type opioïde et leurs utilisations |
JP4957489B2 (ja) * | 2002-10-09 | 2012-06-20 | 東レ株式会社 | 含窒素環状置換基を有するモルヒナン誘導体またはその薬理学的に許容される酸付加塩を含有する医薬 |
US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
JP2011512360A (ja) * | 2008-02-14 | 2011-04-21 | アルカーメス,インコーポレイテッド | 選択的オピオイド化合物 |
CA2894963A1 (fr) * | 2012-12-14 | 2014-06-19 | Purdue Pharma L.P. | Analogues de pyridonemorphinane et activite biologique sur des recepteurs des opioides |
ES2621305T3 (es) * | 2012-12-14 | 2017-07-03 | Purdue Pharma Lp | Morfinanos espirocíclicos y su uso |
AR096851A1 (es) * | 2013-07-11 | 2016-02-03 | H Lundbeck As | Sales que no forman hidratos ni solvatos de nalmefeno |
CA2951697A1 (fr) * | 2014-06-13 | 2015-12-17 | Purdue Pharma L.P. | Derives d'azamophinan et leur utilisation |
-
1986
- 1986-05-09 HU HU861934A patent/HU196376B/hu not_active IP Right Cessation
- 1986-05-12 NL NL8601188A patent/NL8601188A/nl not_active Application Discontinuation
- 1986-05-19 PH PH33785A patent/PH23341A/en unknown
- 1986-05-19 GB GB8612159A patent/GB2175898B/en not_active Expired
- 1986-05-21 SE SE8602308A patent/SE8602308L/xx not_active Application Discontinuation
- 1986-05-21 IL IL78872A patent/IL78872A0/xx unknown
- 1986-05-21 FI FI862124A patent/FI862124A/fi not_active Application Discontinuation
- 1986-05-21 GR GR861318A patent/GR861318B/el unknown
- 1986-05-21 NZ NZ216250A patent/NZ216250A/en unknown
- 1986-05-21 ES ES555200A patent/ES8802318A1/es not_active Expired
- 1986-05-21 AU AU57637/86A patent/AU594954B2/en not_active Expired - Fee Related
- 1986-05-21 BE BE1/011493A patent/BE904796A/fr not_active IP Right Cessation
- 1986-05-22 LU LU86435A patent/LU86435A1/fr unknown
- 1986-05-22 JP JP61118984A patent/JPS61271275A/ja active Pending
- 1986-05-22 DK DK240386A patent/DK240386A/da not_active Application Discontinuation
- 1986-05-23 FR FR8607367A patent/FR2582309B1/fr not_active Expired
- 1986-05-23 IT IT48050/86A patent/IT1203791B/it active
- 1986-05-23 ZA ZA863873A patent/ZA863873B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HUT41737A (en) | 1987-05-28 |
IT8648050A0 (it) | 1986-05-23 |
ES8802318A1 (es) | 1988-05-01 |
HU196376B (en) | 1988-11-28 |
DK240386D0 (da) | 1986-05-22 |
ES555200A0 (es) | 1988-05-01 |
NL8601188A (nl) | 1986-12-16 |
SE8602308D0 (sv) | 1986-05-21 |
FR2582309B1 (fr) | 1989-08-18 |
FI862124A0 (fi) | 1986-05-21 |
GB2175898B (en) | 1989-07-05 |
BE904796A (fr) | 1986-11-21 |
GR861318B (en) | 1986-09-19 |
JPS61271275A (ja) | 1986-12-01 |
AU5763786A (en) | 1986-11-27 |
AU594954B2 (en) | 1990-03-22 |
SE8602308L (sv) | 1986-11-24 |
PH23341A (en) | 1989-07-14 |
GB8612159D0 (en) | 1986-06-25 |
GB2175898A (en) | 1986-12-10 |
NZ216250A (en) | 1990-04-26 |
FR2582309A1 (fr) | 1986-11-28 |
DK240386A (da) | 1986-11-24 |
FI862124A (fi) | 1986-11-24 |
IT1203791B (it) | 1989-02-23 |
ZA863873B (en) | 1988-01-27 |
LU86435A1 (fr) | 1986-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ216793A (en) | Phenethanolaminotetraline derivatives and pharmaceutical compositions | |
NZ217931A (en) | Pyridone derivatives and pharmaceutical compositions | |
NZ220345A (en) | Imidazoquinolinylether derivatives and pharmaceutical compositions containing them | |
NZ216678A (en) | Heterocyclic substituted-phenoxyalkyl-isoxazoles and -furans and pharmaceutical compositions | |
IL78872A0 (en) | Morphinan derivatives and pharmaceutical compositions containing them | |
IL74865A0 (en) | 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them | |
IL79376A0 (en) | Substituted di-t-butylphenols and pharmaceutical compositions containing them | |
IL82205A0 (en) | Substituted alkanesulfonamidophenyl derivatives and pharmaceutical compositions containing them | |
IL76188A (en) | 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them | |
NZ220336A (en) | Isoquinoline derivatives and pharmaceutical compositions containing such | |
NZ214821A (en) | Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions | |
NZ218428A (en) | Heterocyclically-substituted quinoline derivatives and pharmaceutical compositions | |
NZ217220A (en) | Guanine derivatives and pharmaceutical compositions | |
NZ216416A (en) | Benzazepine derivatives and pharmaceutical compositions | |
IL86711A0 (en) | 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them | |
NZ217078A (en) | N-piperidyl-benzamide derivatives and pharmaceutical compositions | |
NZ216894A (en) | Penicillin derivatives and pharmaceutical compositions | |
NZ216720A (en) | Diazinylpiperidine derivatives and pharmaceutical compositions | |
GB2167414B (en) | Flavolignan derivatives and pharmaceutical compositions containing them | |
NZ215070A (en) | Imidazole-indoles and pharmaceutical compositions | |
NZ218098A (en) | Imidazole derivatives and pharmaceutical compositions | |
IL80540A0 (en) | Dihydropyridine derivatives and pharmaceutical compositions containing them | |
IL79003A0 (en) | Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them | |
NZ216438A (en) | Steroid-pyrazoles and pharmaceutical compositions | |
PH24135A (en) | Quinoline derivatives and pharmaceutical composition containing said compounds |